Elanco Animal Health Incorporated is an American pharmaceutical company that develops, manufactures, and markets medicines, parasiticides, vaccines, and productivity products for companion animals (pets) and livestock. Founded in 1954 as the animal health division of Eli Lilly and Company, it became a fully independent public company in 2019 and is listed on the New York Stock Exchange under the ticker ELAN. Headquartered in Indianapolis, Indiana, it is the third-largest animal health company in the world, operating in more than 90 countries with roughly 9,000 employees. Its portfolio includes well-known pet brands such as Seresto, Advantage, Credelio, and Galliprant, as well as farm-animal products like Rumensin and Experior, generating annual revenue of about $4.7 billion.
| Import | Export |
|---|---|
|
Trade Records
327
|
Trade Records
74
|
|
Suppliers
10
|
Buyers
7
|
|
Latest Import Date
2026-08
|
Latest Export Date
2026-08
|
According to Topease's global trade data, ELANCO US INC. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the ELANCO US INC. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, ELANCO US INC. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore ELANCO US INC.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| ELANCO ANIMAL HEALTH INC. | ELANCO US INC. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| ELANCO UK AH LİMİTED | ELANCO US INC. | 3003 | 24 | $186,500 | 3,420 | Los Angeles |
| EURO NUTEC PREMIX S.A. DE C.V. | ELANCO US INC. | 2309 | 24 | $186,500 | 3,420 | Los Angeles |
| DANZAS CORPORATION DBA DANMAR LIN | ELANCO US INC. | — | 24 | $186,500 | 3,420 | Los Angeles |
| DATAMARS (THAILAND) LTD | ELANCO US INC. | 9018 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into ELANCO US INC.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| NOVARTIS SALUD ANIMAL S.A. DE C.V. | ELANCO US INC. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| ELANCO COLOMBIA SAS | ELANCO US INC. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| PT ELANCO ANIMAL HEALTH INDONESIA | ELANCO US INC. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| ELANCO M SDN BHD | ELANCO US INC. | 3002 | 24 | $186,500 | 3,420 | Los Angeles |
| NOVELTAI TRADING PVT. LTD. | ELANCO US INC. | 3507 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore ELANCO US INC.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access ELANCO US INC.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.